SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring (LTCM ...

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio® long-term continuous ECG monitoring (LTCM ...

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC) (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring ...

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring (LTCM) system, ...

and increased demand for Zio AT and Zio Monitor products internationally. The company surpassed a significant milestone with 10 million cumulative patient reports since inception, emphasizing its ...

Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 20.3% year on year to $158.7 million. The company’s ...

iRhythm announced the commercial launch of its Zio long-term continuous ECG monitoring (LTCM) system, commercially introduced in Japan as the Zio ECG Recording and Analysis System. Guidance ...

The company maintains over 70% market share in the Long-Term Continuous Monitoring (LTCM) segment with its Zio monitor and over 10% share in Mobile Cardiac Telemetry (MCT) with Zio AT.